Predictors of left ventricular hypertrophy and their cutoffs in peritoneal dialysis patients

International Heart Journal

Volumn 56, Issue 2, 2015, Pages 186-191

  Hassan, Kamal ^a,b   Hassan, Shadi ^c   Anwar, Saab ^d   Zaher, Armaly ^e   Edgem, Rabia ^b   Hassan, Fadi ^f  

^a BAR ILAN UNIVERSITY   (Israel)

^b WESTERN GALILEE HOSPITAL   (Israel)

^c CARMEL MEDICAL CENTER   (Israel)

^d CLALIT HEALTH SERVICES   (Israel)

^e Edinburgh Medical Missionary Society   (Israel)

^f TEL AVIV UNIVERSITY   (Israel)

Author keywords

Fluid overload; Glucose load; Inflammation; Left ventricular mass

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM ALBUMIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD PRESSURE; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLUCOSE TOLERANCE TEST; HEART LEFT VENTRICLE HYPERTROPHY; HEMATOCRIT; HUMAN; HYPERVOLEMIA; INFLAMMATION; KIDNEY FUNCTION; MALE; MIDDLE AGED; PARAMETERS; PERITONEAL DIALYSIS; PERITONEAL GLUCOSE LOAD INDEX; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ULTRAFILTRATION; URINE VOLUME; AGED; BLOOD; COMPLICATION; GLUCOSE BLOOD LEVEL; HYPERTROPHY, LEFT VENTRICULAR; METABOLISM; PREDICTIVE VALUE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84929940049     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.14-246     Document Type: Article

References (30)

1. Locatelli F, Covic A, Chazot C, et al. Hypertension and cardiovas-cular risk assessment in dialysis patients. Nephrol Dial Transplant 2000; 15: 69-80. (Review).
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prog-nostic implications of echocardiographically determined left ven-tricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6.
3. Van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with continuous ambula-tory peritoneal dialysis. J Am Soc Nephrol 1996; 7: 745-50.
4. Wang AY, Lam CW, Wang M, et al. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Nephrol Dial Transplant 2009; 24: 1962-9.
5. Moissl UM, Wabel P, Chamney PW, et al. Body fluid volume de-termination via body composition spectroscopy in health and dis-ease. Physiol Meas 2006; 27: 921-33.
6. Devereux RB, Alonso DR, Lutas EM, et al. Electrocardiographic assessment of left ventricular hypertrophy: comparison to necrop-sy findings. Am J Cardiol 1986; 57: 450-8.
7. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-63.
8. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992; 117: 831-6.
9. Ataş N, Erten Y, Okyay GU, et al. Left ventricular hypertrophy and blood pressure control in automated and continuous ambula-tory peritoneal dialysis patients. Ther Apher Dial 2014; 18: 297-304.
10. Inal S, Erten Y, Okyay GU, et al. Association between bioimped-ance analysis parameters and left ventricular hypertrophy in peri-toneal dialysis patients. Int Urol Nephrol 2014; 46: 1851-6.
11. Tonbul Z, Altintepe L, Sözlü C, Yeksan M, Yildiz A, Türk S. The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int 2003; 23: 46-52.
12. Chen KH, Lin JL, Lin-Tan DT, et al. Glycated hemoglobin pre-dicts mortality in nondiabetic patients receiving chronic peritoneal dialysis. Am J Nephrol 2010; 32: 567-74.
13. Chiu YW, Mehrotra R. Can we reduce the cardiovascular risk in peritoneal dialysis patients? Indian J Nephrol 2010; 20: 59-67.
14. Duong U, Mehrotra R, Molnar MZ, et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol 2011; 5: 1041-8.
15. Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW. Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 1981; 19: 564-7.
16. Fortes PC, de Moraes TP, Mendes JG, Stinghen AE, Ribeiro SC, Pecoits-Filho R. Insulin resistance and glucose homeostasis in peritoneal dialysis. Perit Dial Int 2009; 29: S145-8. (Review).
17. Velcheva I, Damianov P, Mantarova S, Antonova N. Hemorheolo-gy and heart rate variability in patients with diabetes mellitus type 2. Clin Hemorheol Microcirc 2011; 49: 513-8.
18. Hassan K, Roguin N, Kaganov Y, Hasan S, Kristal B. Effect of erythropoietin therapy on red cells filterability and left ventricular mass in predialysis patients. Ren Fail 2005; 27: 177-82.
19. Devereux RB, Drayer JI, Chien S, et al. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol 1984; 54: 592-5.
20. Krediet RT, Zuyderhoudt FMJ, Boeschoten EW, Arisz L. Perito-neal permeability to proteins in diabetic and non diabetic continu-ous ambulatory peritoneal dialysis patients. Nephron 1986; 42: 133-40.
21. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl 2006: S3-11. (Review).
22. Crepaldi C, Lamas EI, Martino FK, et al. Bioimpedance and brain natriuretic peptide in peritoneal dialysis patients. Contrib Nephrol 2012; 178: 174-81. (Review).
23. Vicenté-Martínez M, Martínez-Ramírez L, Muñoz R, et al. In-flammation in patients on peritoneal dialysis is associated with in-creased extracellular fluid volume. Arch Med Res 2004; 35: 220-4.
24. Lundsgaard-Hansen P, Blauhut B. Relation of hypoxia and edema of the intestinal wall and skin to colloid osmotic pressure. Anaes-thesist 1988; 37: 112-9. (German).
25. Gonçalves S, Pecoits-Filho R, Perreto S, et al. Associations be-tween renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transplant 2006; 21: 2788-94.
26. Yu Z, Tan BK, Dainty S, Mattey DL, Davies SJ. Hypoalbuminae-mia, systemic albumin leak and endothelial dysfunction in perito-neal dialysis patients. Nephrol Dial Transplant 2012; 27: 4437-45.
27. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. In-flammation enhances cardiovascular risk and mortality in hemodi-alysis patients. Kidney Int 1999; 55: 648-58.
28. Ducloux D, Bresson-vautrin C, Kribs M, Abdelfatah A, Chalopin JM. C-reactive protein and cardiovascular disease in peritoneal di-alysis patients. Kidney Int 2002; 62: 1417-22.
29. Monfared A, Salari A, Kazemnezhad E, et al. Association of left ventricular hypertrophy with high-sensitive C-reactive protein in hemodialysis patients. Int Urol Nephrol 2013; 45: 1679-86.
30. van der Walt C, Malan L, Uys AS, Malan NT. Low grade inflam-mation and ECG left ventricular hypertrophy in urban African males: The SABPA study. Heart Lung Circ 2013; 22: 924-9.